nach oben

Current Neurology and Neuroscience Reports

Erschienen in:

01.07.2021 | Sleep (M. Thorpy and M. Billiard, Section Editors)

Effects of Obstructive Sleep Apnea and CPAP on Cognitive Function

verfasst von: Gilbert Seda, Gregory Matwiyoff, John S. Parrish

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Obstructive sleep apnea (OSA) is characterized by repetitive episodes of complete or partial upper airway obstruction during sleep. Studies indicate that OSA is an independent risk factor for cognitive decline in older patients. The purpose of this paper is to critically review the recent literature on the cognitive effects of untreated OSA and the benefits of treatment across cognitive domains.

Recent Findings

OSA’s greatest impact appears to be on attention, vigilance, and information processing speed. Furthermore, the presence of OSA seems to have a significant impact on development and progression of mild cognitive impairment (MCI). Impact of OSA treatment, particularly with CPAP, appears to mitigate and slow the rate of cognitive decline and may reduce the risk of dementia.

Summary

Larger properly controlled studies, of a prospective nature, are required to further elucidate the degree of treatment effect. More studies are needed on other treatments for OSA such as oral mandibular devices and hypoglossal nerve stimulation.

Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7:687–98. https://doi.org/10.1016/S2213-2600(19)30198-5.CrossRefPubMedPubMedCentral

Patel SR. Obstructive sleep apnea. Ann Intern Med. 2019;171:ITC81–96. https://doi.org/10.7326/AITC201912030.CrossRefPubMed

Semelka M, Wilson J, Floyd R. Diagnosis and treatment of obstructive sleep apnea in adults. Am Fam Physician. 2016;94:355–60.PubMed

Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. JAMA. 2020;323:1389–400. https://doi.org/10.1001/jama.2020.3514.CrossRefPubMed

Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest. 1997;99:106–9.CrossRef

Peppard P, Young T, Palta M, Skatrud J. Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med. 2000;342:1378–84.CrossRef

Lavie P, Here P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension. BMJ. 2000;320:479–82.CrossRef

Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, et al. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens. 2012;30:633–46.CrossRef

Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. 2014;383:736–47. https://doi.org/10.1016/S0140-6736(13)60734-5.CrossRefPubMed

10.

Gami AS, Olson EJ, Shen WK, Wright RS, Ballman KV, Hodge DO, et al. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol. 2013;62:610–6. https://doi.org/10.1016/j.jacc.2013.04.080.CrossRefPubMed

11.

Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034–41. https://doi.org/10.1056/NEJMoa043104.CrossRefPubMed

12.

Garbarino S, Bardwell WA, Guglielmi O, Chiorri C, Bonanni E, Magnavita N. Association of anxiety and depression in obstructive sleep apnea patients: a systematic review and meta-analysis. Behav Sleep Med. 2020;18:35–57. https://doi.org/10.1080/15402002.2018.1545649.CrossRefPubMed

13.

Emamian F, Khazaie H, Tahmasian M, Leschziner GD, Morrell MJ, Hsiung GY, et al. The association between obstructive sleep apnea and Alzheimer's disease: a meta-analysis perspective. Front Aging Neurosci. 2016;8:78. https://doi.org/10.3389/fnagi.2016.00078.CrossRefPubMedPubMedCentral

14.

Seda G, Han TS. Effect of obstructive sleep apnea on neurocognitive performance. Sleep Med Clin. 2020;15:77–85. https://doi.org/10.1016/j.jsmc.2019.10.001.CrossRefPubMed

15.••

Prabhakar NR, Peng YJ, Nanduri J. Hypoxia-inducible factors and obstructive sleep apnea. J Clin Invest. 2020;130:5042–51. https://doi.org/10.1172/JCI137560This paper reviews the role of intermittent hypoxia in vascular disease, metabolic disease, and cognitive impairment.

16.

Alomri RM, Kennedy GA, Wali SO, Ahejaili F, Robinson SR. Differential associations of hypoxia, sleep fragmentation and depressive symptoms with cognitive dysfunction in obstructive sleep apnoea. Sleep. . https://doi.org/10.1093/sleep/zsaa213.

17.

Liu S, Shen J, Li Y, Wang J, Wang J, Xu J, et al. EEG power spectral analysis of abnormal cortical activations during REM/NREM sleep in obstructive sleep apnea. Front Neurol. 2021. https://doi.org/10.3389/fneur.2021.643855.

18.••

Zhu X, Zhao Y. Sleep-disordered breathing and the risk of cognitive decline: a meta-analysis of 19,940 participants. Sleep Breath. 2018;22:165–73. https://doi.org/10.1007/s11325-017-1562-xMeta-analysis of cohort studies to evaluate the association between SDB and cognitive decline. SDB may be an independent risk factor for the developing of cognitive decline, and gender difference may exist regarding this association.

19.

Mubashir T, Abrahamyan L, Niazi A, Piyasena D, Arif AA, Wong J, et al. The prevalence of obstructive sleep apnea in mild cognitive impairment: a systematic review. BMC Neurol. 2019;19:195. https://doi.org/10.1186/s12883-019-1422-3.CrossRefPubMedPubMedCentral

20.

Caporale M, Palmeri R, Corallo F, Muscarà N, Romeo L, Bramanti A, et al. Cognitive impairment in obstructive sleep apnea syndrome: a descriptive review. Sleep Breath. 2021;25:29–40. https://doi.org/10.1007/s11325-020-02084-3.CrossRefPubMed

21.••

Beaudin AE, Raneri JK, Ayas NT, Skomro RP, Fox N, Hirsch Allen AM, et al. Cognitive function in a sleep clinic cohort of patients with obstructive sleep apnea. Ann Am Thorac Soc. 2020. https://doi.org/10.1513/AnnalsATS.202004-313OCThis study found that cognitive impairment is highly prevalent in patients referred to sleep clinics for suspected OSA, occurring predominantly in older males with moderate-to-severe OSA and concurrent vascular comorbidities. Moderate-to-severe OSA is an independent risk factor for MCI.

22.

Olaithe M, Bucks RS. Executive dysfunction in OSA before and after treatment: a meta-analysis. Sleep. 2013;36:1297–305. https://doi.org/10.5665/sleep.2950.CrossRefPubMedPubMedCentral

23.

Suchy Y. Executive functioning: overview, assessment, and research issues for non-neuropsychologists. Ann Behav Med. 2009;37:106–16.CrossRef

24.

Fisk JE, Sharp CA. Age-related impairment in executive functioning: updating, inhibition, shifting, and access. J Clin Exp Neuropsychol. 2004;26:874–90.CrossRef

25.

Adrover-Roig D, Sesé A, Barceló F, Palmer A. A latent variable approach to executive control in healthy ageing. Brain Cogn. 2012;78:284–99. https://doi.org/10.1016/j.bandc.2012.01.005.CrossRefPubMed

26.••

Angelelli P, Macchitella L, Toraldo DM, Abbate E, Marinelli CV, Arigliani M, et al. The neuropsychological profile of attention deficits of patients with obstructive sleep apnea: an update on the daytime attentional impairment. Brain Sci. 2020;10:325. https://doi.org/10.3390/brainsci10060325This study compared moderate to severe OSA patients matched to healthy controls on attention and vigilance. Patients with severe OSA and severe hypoxemia underperformed on alertness and vigilance attention subtests.

27.

Huang Y, Hennig S, Fietze I, Penzel T, Veauthier C. The psychomotor vigilance test compared to a divided attention steering simulation in patients with moderate or severe obstructive sleep apnea. Nat Sci Sleep. 2020;12:509–24. https://doi.org/10.2147/NSS.S256987.CrossRefPubMedPubMedCentral

28.

Shen YC, Kung SC, Chang ET, Hong YL, Wang LY. The impact of obesity in cognitive and memory dysfunction in obstructive sleep apnea syndrome. Int J Obes. 2019;43:355–61. https://doi.org/10.1038/s41366-018-0138-6.CrossRef

29.

McCloy K, Duce B, Swarnkar V, Hukins C, Abeyratne U. Polysomnographic risk factors for vigilance-related cognitive decline and obstructive sleep apnea. Sleep Breath. 2021;25:75–83. https://doi.org/10.1007/s11325-020-02050-z.CrossRefPubMed

30.

Duce B, Kulkas A, Töyräs J, Terrill P, Hukins C. Longer duration electroencephalogram arousals have a better relationship with impaired vigilance and health status in obstructive sleep apnoea. Sleep Breath. 2021;25:263–70. https://doi.org/10.1007/s11325-020-02110-4.CrossRefPubMed

31.••

Sivam S, Poon J, Wong KKH, Yee BJ, Piper AJ, D'Rozario AL, et al. Slow-frequency electroencephalography activity during wake and sleep in obesity hypoventilation syndrome. Sleep. 2020;43:zsz214. https://doi.org/10.1093/sleep/zsz214This study showed that patients with OHS have greater slow frequency EEG activity during sleep and wake than equally obese patients with OSA. Greater EEG slowing was associated with worse vigilance and lower oxygenation during sleep.

32.••

Kushida CA, Nichols DA, Holmes TH, Quan SF, Walsh JK, Gottlieb DJ, et al. Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: the apnea positive pressure long-term efficacy study (APPLES). Sleep. 2012;35:1593–602. https://doi.org/10.5665/sleep.2226The APPLES study was a 6-month, randomized, double-blind, 2-arm, sham-controlled, multicenter trial conducted at 5 U.S. university, hospital, or private practices. Of 1,516 participants enrolled, 1,105 were randomized, and 1,098 participants diagnosed with OSA contributed to the analysis of the primary outcome measures. CPAP treatment improved both subjectively and objectively measured sleepiness, especially in individuals with severe OSA (AHI > 30).

33.

Wang ML, Wang C, Tuo M, Yu Y, Wang L, Yu JT, et al. Cognitive effects of treating obstructive sleep apnea: a meta-analysis of randomized controlled trials. J Alzheimers Dis. 2020;75:705–15. https://doi.org/10.3233/JAD-200088.CrossRefPubMed

34.

Bhat S, Gupta D, Akel O, Polos PG, DeBari VA, Akhtar S, et al. The relationships between improvements in daytime sleepiness, fatigue and depression and psychomotor vigilance task testing with CPAP use in patients with obstructive sleep apnea. Sleep Med. 2018;49:81–9. https://doi.org/10.1016/j.sleep.2018.06.012.CrossRefPubMed

35.

Turner K, Zambrelli E, Lavolpe S, Baldi C, Furia F, Canevini MP. Obstructive sleep apnea: neurocognitive and behavioral functions before and after treatment. Funct Neurol. 2019;34(2):71–8.PubMed

36.

Dostálová V, Kolečkárová S, Kuška M, Pretl M, Bezdicek O. Effects of continuous positive airway pressure on neurocognitive and neuropsychiatric function in obstructive sleep apnea. J Sleep Res. 2019;28:e12761. https://doi.org/10.1111/jsr.12761.CrossRefPubMed

37.••

Dunietz GL, Chervin RD, Burke JF, Conceicao AS, Braley TJ. Obstructive sleep apnea treatment and dementia risk in older adults. Sleep. 2021. https://doi.org/10.1093/sleep/zsab076This large retrospective study utilized Medicare 5% fee-for-service claims data of 53,321 beneficiaries, aged 65+, with an OSA diagnosis to examine associations between PAP therapy, adherence and incident diagnoses of Alzheimer's disease (AD), mild cognitive impairment (MCI), and dementia not-otherwise-specified (DNOS) in older adults. PAP treatment and adherence were independently associated with lower odds of incident AD diagnoses in older adults. Results suggest that treatment of OSA may reduce risk of subsequent dementia. Lower odds of MCI, approaching statistical significance, were also observed among PAP users.

38.

Wang Y, Cheng C, Moelter S, Fuentecilla JL, Kincheloe K, Lozano AJ, et al. One year of continuous positive airway pressure adherence improves cognition in older adults with mild apnea and mild cognitive impairment. Nurs Res. 2020;69:157–64. https://doi.org/10.1097/NNR.0000000000000420.CrossRefPubMedPubMedCentral

39.

Richards KC, Gooneratne N, Dicicco B, Hanlon A, Moelter S, Onen F, et al. CPAP adherence may slow 1-year cognitive decline in older adults with mild cognitive impairment and apnea. J Am Geriatr Soc. 2019;67:558–64. https://doi.org/10.1111/jgs.15758.CrossRefPubMedPubMedCentral

40.

Skiba V, Novikova M, Suneja A, McLellan B, Schultz L. Use of positive airway pressure in mild cognitive impairment to delay progression to dementia. J Clin Sleep Med. 2020;16:863–70. https://doi.org/10.5664/jcsm.8346.CrossRefPubMed

41.

Enciso R. Effects of CPAP and mandibular advancement device treatment in obstructive sleep apnea patients: a systematic review and meta-analysis. Sleep Breath. 2018;22:555–68. https://doi.org/10.1007/s11325-017-1590-6.CrossRefPubMed

Titel: Effects of Obstructive Sleep Apnea and CPAP on Cognitive Function
verfasst von: Gilbert Seda
Gregory Matwiyoff
John S. Parrish
Publikationsdatum: 01.07.2021
Verlag: Springer US
Erschienen in: Current Neurology and Neuroscience Reports / Ausgabe 7/2021
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI: https://doi.org/10.1007/s11910-021-01123-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2021

Central Nervous System Infections in Immunocompromised Patients

Neurologic Complications of Poverty: the Associations Between Poverty as a Social Determinant of Health and Adverse Neurologic Outcomes

Sleep Disorders in Mitochondrial Diseases

Effects of the Menstrual Cycle on Neurological Disorders

Cluster Headache: A Review and Update in Treatment